09 Jan 2017
N+1 Singer - EKF Diagnostics - Strong end to FY16 caps remarkable turnaround
The strong recovery in trading has continued, meaning the outcome for the year just ended will exceed market expectations (which had already been revised up twice in the year). We push through further upgrades of 10-11% at the EPS level and see scope for further top and bottom line progression. In our view, the shares remain very attractively valued at 1.9x EV/Sales and 10x EV/EBITDA. With a rapidly strengthening balance sheet and margins improving towards industry norms, the business is well s ....
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
N+1 Singer - EKF Diagnostics - Strong end to FY16 caps remarkable turnaround
EKF Diagnostics Holdings plc (EKF:LON) | 27.8 0.3 4.5% | Mkt Cap: 126.1m
- Published:
09 Jan 2017 -
Author:
Chris Glasper -
Pages:
3
The strong recovery in trading has continued, meaning the outcome for the year just ended will exceed market expectations (which had already been revised up twice in the year). We push through further upgrades of 10-11% at the EPS level and see scope for further top and bottom line progression. In our view, the shares remain very attractively valued at 1.9x EV/Sales and 10x EV/EBITDA. With a rapidly strengthening balance sheet and margins improving towards industry norms, the business is well s ....